In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

an annual meeting highlighting progress in the weight loss arena. For example, during the event, AstraZeneca shared promising ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

According to the American Association of Nurse Practitioners, there are more than 385,000 nurse practitioners (NPs) licensed in the United States. NPs ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Use of the weight loss drug was also linked to shorter hospital stays. Eli Lilly and Novo Nordisk are the main players in the GLP-1 field, but they're facing competition from compounding pharmacies, ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...